759.86
-5.07(-0.66%)
Currency In USD
| Previous Close | 764.93 |
| Open | 758.9 |
| Day High | 762.7 |
| Day Low | 747.82 |
| 52-Week High | 821.11 |
| 52-Week Low | 476.49 |
| Volume | 561,908 |
| Average Volume | 824,394 |
| Market Cap | 78.95B |
| PE | 18.31 |
| EPS | 41.49 |
| Moving Average 50 Days | 771.72 |
| Moving Average 200 Days | 642.39 |
| Change | -5.07 |
If you invested $1000 in Regeneron Pharmaceuticals, Inc. (REGN) 10 years ago, it would be worth $2,027.65 as of March 09, 2026 at a share price of $759.86. Whereas If you bought $1000 worth of Regeneron Pharmaceuticals, Inc. (REGN) shares 5 years ago, it would be worth $1,614.56 as of March 09, 2026 at a share price of $759.86.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients
GlobeNewswire Inc.
1 hours ago
Patients treated with olatorepatide achieved up to 19% body-weight loss at week 48 Regeneron’s global Phase 3 registrational program to be initiated later this year TARRYTOWN, N.Y., March 09, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc
Regeneron Announces Investor Conference Presentation
GlobeNewswire Inc.
Mar 05, 2026 9:05 PM GMT
TARRYTOWN, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation at the Barclays 28th Annual Global Healthcare Conference at 9:00 a.m. ET on Tuesday, March 10, 2026. The sessio
Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
GlobeNewswire Inc.
Feb 26, 2026 5:00 PM GMT
Key Takeaways: Regeneron will extend its title sponsorship of the Regeneron Science Talent Search (STS) for a second decade, continuing its partnership with Society for Science to support the United States’ oldest and most prestigious science and mat